Credelio Plus
-
EU/2/21/271/015
Elanco GmbH, Vācija
QP54AB51
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner, Milbemycin oxime
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
14-Apr-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/271/015
1
Al/Al blisteris, 6 tablete
-
Bovela
-
EU/2/14/176/007
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI02AD02
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Animal Health USA Inc., ASV
Date of authorisation/renewal:
21-Dec-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/14/176/007
6
Stikla flakons, 10 deva
-
Broadline
-
EU/2/13/157/009
Boehringer Ingelheim Vetmedica GmbH, Vācija
QP54AA54
large cats
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Fipronil,Praziquantel,S-Methoprene,Eprinomectin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Merial, Francija
Date of authorisation/renewal:
24-Sep-2018
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/13/157/009
15
Polipropilēna aplikators, 1 deva
-
Metacam
0.5 mg/ml
EU/2/97/004/033
Boehringer Ingelheim Vetmedica GmbH, Vācija
QM01AC06
guinea pigs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal:
20-Nov-2009
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/97/004/033
0,5 mg/ml
1
Plastmasas pudele, 10 ml
-
Advocate Spot-on šķīdums lieliem suņiem
-
EU/2/03/039/049
Bayer Animal Health , Vācija
QP54AB52
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Moxidectin,Imidacloprid
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
16-Jul-2007
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/03/039/049
9
Pipete, 2,5 ml
-
Bovela
-
EU/2/14/176/012
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI02AD02
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Animal Health USA Inc., ASV
Date of authorisation/renewal:
21-Dec-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/14/176/012
10
Stikla flakons, 25 deva
-
Rheumocam
1.5 mg/ml
EU/2/07/078/003
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal:
10-Jan-2008
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/07/078/003
1,5 mg/ml
1
Šļirce, 200 ml
-
Melosus
0.5 mg/ml
EU/2/10/116/007
CP-Pharma Handelsgesellschaft GmbH, Vācija
QM01AC06
guinea pigs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal:
07-Jan-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/10/116/007
1
PET pudele, 5 ml
-
CYTOPOINT
10.0 mg/ml
EU/2/17/205/001
Zoetis Belgium S.A., Beļģija
QD11AH91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Lokivetmab
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
26-Apr-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/205/001
10 mg/ml
2
Stikla flakons, 1 deva
-
Lotilaner/Milbemycin Elanco 112,5 mg/4,22 mg
-
EU/2/26/361/005
Elanco GmbH, Vācija
QP54AB51
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner, Milbemycin oxime
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
25-Feb-2026
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/26/361/005
1
Al/Al blisteris, 1 tablete
-
Novaquin
15.0 mg/ml
EU/2/15/186/002
Le Vet Beheer B.V., Nīderlande
QM01AC06
horses
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal:
24-Jun-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/15/186/002
1
ABPE pudelīte, 336 ml
-
Melovem
20 mg/ml
EU/2/09/098/004
Dopharma Research B.V., Nīderlande
QM01AC06
cattle; pigs; horses
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Dopharma B.V., Nīderlande
Date of authorisation/renewal:
06-Jun-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/09/098/004
20 mg/ml
1
Stikla flakons, 250 ml
-
Fluralaner Intervet
560 mg
EU/2/25/346/017
Intervet International B.V., Nīderlande
QP53BE02
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Fluralaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
27-Jun-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/346/017
1
Blisteris, 1 tablete
-
Daxocox
45 mg
EU/2/21/270/018
Ecuphar NV, Beļģija
QM01AH95
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Enflicoxib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Lelypharma B.V., Nīderlande
Date of authorisation/renewal:
20-Apr-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/270/018
45 mg
4
Blisteris, 5 tablete
-
Canigen L4
-
EU/2/15/183/001
Intervet International B.V., Nīderlande
QI07AB01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000),L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001),L. interrogans serogroup Australis serovar Bratislava (strain As-05-073),L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet International B.V., Nīderlande
Date of authorisation/renewal:
02-Jul-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/15/183/001
10
Stikla flakons, 1 deva
-
Nobivac LoVo L4
-
EU/2/23/304/002
Intervet International B.V., Nīderlande
QI07AB01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated, Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
20-Nov-2023
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/23/304/002
50
Stikla flakons, 1 ml/deva
-
Simparica
120 mg/tabl.
EU/2/15/191/017
Zoetis Belgium S.A., Beļģija
QP53BE03
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Sarolaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
12-Aug-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/15/191/017
1
Al/Al blisteris, 3 tablete
-
Syvazul BTV
-
EU/2/18/231/007
Laboratorios SYVA S.A.U, Spānija
QI04AA02
cattle; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Inactivated bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1, Inactivated bluetongue virus, serotype 4, strain SPA-1/2004
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
LABORATORIOS SYVA, S.A.U. , Spānija
Date of authorisation/renewal:
09-Jan-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/18/231/007
1
Polipropilēna flakons, 80 ml
-
CircoMax
-
EU/2/21/281/002
Zoetis Belgium S.A., Beļģija
QI09AA07
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a ORF2 protein, Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
11-Jan-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/281/002
1
ABPE flakons, 100 ml
-
Carprofen Orion
100 mg/tabl.
EU/2/24/328/007
Orion Corporation, Somija
QM01AE91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
Chewable tablet
International name (active substance):
Carprofen
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
19-Dec-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/328/007
100 mg/tabl.
1
ABPE pudele, 180 tablete
-